Search research articles
Contact Us
Filters
Showing results (161-170 of 180) with videos related to
Page
of 18
Sort By:
The Journal of Experimental Medicine
|
May 2, 2019
A novel human <i>IL2RB</i> mutation results in T and NK cell-driven immune dysregulation
Isabel Z Fernandez, Ryan M Baxter, Josselyn E Garcia-Perez, et al.
Journal for Immunotherapy of Cancer
|
August 6, 2021
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia
John E Levine, Stephan A Grupp, Michael A Pulsipher, et al.
Blood Advances
|
November 13, 2019
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
Peter Bader, Emilia Salzmann-Manrique, Adriana Balduzzi, et al.
Blood Advances
|
April 28, 2022
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
Adam J Lamble, Regina M Myers, Agne Taraseviciute, et al.
Blood Advances
|
August 8, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium
Heather E Stefanski, Anne Eaton, Christina Baggott, et al.
Blood Advances
|
November 18, 2021
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report
Vanessa A Fabrizio, Christine L Phillips, Adam Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2022
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia
Liora M Schultz, Anne Eaton, Christina Baggott, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 2, 2015
Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research
Michael J Burke, Michael R Verneris, Jennifer Le Rademacher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 24, 2018
Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia
Troy C Lund, Kwang Woo Ahn, Heather R Tecca, et al.
Blood Advances
|
May 17, 2022
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia
Amy Moskop, Lauren Pommert, Christina Baggott, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 180) with videos related to
Sort By:
Page
of 18
The Journal of Experimental Medicine
|
May 2, 2019
A novel human <i>IL2RB</i> mutation results in T and NK cell-driven immune dysregulation
Isabel Z Fernandez, Ryan M Baxter, Josselyn E Garcia-Perez, et al.
Journal for Immunotherapy of Cancer
|
August 6, 2021
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia
John E Levine, Stephan A Grupp, Michael A Pulsipher, et al.
Blood Advances
|
November 13, 2019
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling
Peter Bader, Emilia Salzmann-Manrique, Adriana Balduzzi, et al.
Blood Advances
|
April 28, 2022
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells
Adam J Lamble, Regina M Myers, Agne Taraseviciute, et al.
Blood Advances
|
August 8, 2022
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium
Heather E Stefanski, Anne Eaton, Christina Baggott, et al.
Blood Advances
|
November 18, 2021
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report
Vanessa A Fabrizio, Christine L Phillips, Adam Lane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2022
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia
Liora M Schultz, Anne Eaton, Christina Baggott, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 2, 2015
Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research
Michael J Burke, Michael R Verneris, Jennifer Le Rademacher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 24, 2018
Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia
Troy C Lund, Kwang Woo Ahn, Heather R Tecca, et al.
Blood Advances
|
May 17, 2022
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia
Amy Moskop, Lauren Pommert, Christina Baggott, et al.
Page
of 18